Illumina, Inc. (ILMN)
120.00
-0.09
(-0.07%)
USD |
NASDAQ |
Feb 19, 16:00
118.00
-2.00
(-1.67%)
After-Hours: 20:00
Illumina Research and Development Expense (Quarterly) : 238.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Guardant Health, Inc. | 89.96M |
| Natera, Inc. | 173.41M |
| GeneDx Holdings Corp. | 19.59M |
| EXACT Sciences Corp. | 191.50M |
| Mettler-Toledo International, Inc. | 52.60M |